#aae? ,,congress #a/ ,session ,s4 #bjd ,,an ,,act ,to au?orize ! use ( unapprov$ m$ical products by pati5ts diagnos$ ) a t]m9al illness 9 accordance ) ,/ate law1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,trickett ,w5dl]1 ,frank ,mongiello1 ,jordan ,mc,linn1 & ,mat!w ,bell9a ,"r to ,try ,act ( #bjag4 #b4 ,use ( unapprov$ inve/igational drugs by pati5ts diagnos$ ) a t]m9al illness 7a7 ,9 g5]al ,*apt] ,v ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act is am5d$ by ins]t+ aft] section #efa;,a 7#ba ,u4,s4,c4 #cfj;bbb-#j7 ! foll[+3 #efa;,b4 ,inve/igational drugs = use by eligible pati5ts 7a7 ,def9itions ,= purposes ( ?is section-- 7#a7 ! t]m eligible pati5t means a pati5t-- 7,a7 :o has be5 diagnos$ ) a life-?reat5+ disease or condition 7z def9$ 9 section #cab4ha ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations772 7,b7 :o has exhau/$ approv$ treatm5t options & is unable to p>ticipate 9 a cl9ical trial involv+ ! eligible inve/igational drug1 z c]tifi$ by a physician1 :o-- 7i7 is 9 good /&+ ) ! physician's lic5s+ organization or bo>d2 & 7ii7 w n be comp5sat$ directly by ! manufactur] = s c]tify+2 & 7,c7 :o has provid$ to ! treat+ physician writt5 in=m$ cons5t reg>d+ ! eligible inve/igational drug1 or1 z applicable1 on ^: behalf a legally au?oriz$ repres5tative ( ! pati5t has provid$ su* cons5t2 7#b7 ! t]m eligible inve/igational drug means an inve/igational drug 7z su* t]m is us$ 9 section #efa7-- 7,a7 = :i* a ,phase #a cl9ical trial has be5 complet$2 7,b7 t has n be5 approv$ or lic5s$ = any use "u section #eje ( ?is ,act or section #cea ( ! ,public ,heal? ,s]vice ,act2 7,c7 7i7 = :i* an application has be5 fil$ "u section #eje7;b7 ( ?is ,act or section #cea7;a7 ( ! ,public ,heal? ,s]vice ,act2 or 7ii7 t is "u inve/igation 9 a cl9ical trial t-- 7,i7 is int5d$ to =m ! prim>y basis ( a claim ( effectiv5ess 9 support ( approval or lic5sure "u section #eje ( ?is ,act or section #cea ( ! ,public ,heal? ,s]vice ,act2 & 7,,ii7 is ! subject ( an active inve/igational new drug application "u section #eje7;i7 ( ?is ,act or section #cea7;a77#c7 ( ! ,public ,heal? ,s]vice ,act1 z applicable2 & 7,d7 ! active developm5t or production ( :i* is ongo+ & has n be5 discont9u$ by ! manufactur] or plac$ on cl9ical hold "u section #eje7;i72 & 7#c7 ! t]m phase #a trial means a phase #a cl9ical inve/igation ( a drug z describ$ 9 section #cab4ba ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations74 7b7 ,exemptions ,eligible inve/igational drugs provid$ to eligible pati5ts 9 compliance ) ?is section are exempt f sections #ejb7;f71 #ejc7;b77#d71 #eje7;a71 & #eje7;i7 ( ?is ,act1 section #cea7;a7 ( ! ,public ,heal? ,s]vice ,act1 & p>ts #ej1 #ef1 & #cab ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations71 provid$ t ! sponsor ( su* eligible inve/igational drug or any p]son :o manufactures1 di/ributes1 prescribes1 disp5ses1 introduces or deliv]s = introduction into int]/ate comm]ce1 or provides to an eligible pati5t an eligible inve/igational drug pursuant to ?is section is 9 compliance ) ! applicable requirem5ts set =? 9 sections #cab4f1 #cab4g1 & #cab4h7;d77#a7 ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations7 t apply to inve/igational drugs4 7c7 ,use ( cl9ical outcomes 7#a7 ,9 g5]al ,not)/&+ any o!r provision ( ?is ,act1 ! ,public ,heal? ,s]vice ,act1 or any o!r provision ( ,f$]al law1 ! ,secret>y may n use a cl9ical outcome associat$ ) ! use ( an eligible inve/igational drug pursuant to ?is section to delay or adv]sely affect ! review or approval ( su* drug "u section #eje ( ?is ,act or section #cea ( ! ,public ,heal? ,s]vice ,act unless-- 7,a7 ! ,secret>y makes a det]m9ation1 9 accordance ) p>agraph 7#b71 t use ( su* cl9ical outcome is critical to det]m9+ ! safety ( ! eligible inve/igational drug2 or 7,b7 ! sponsor reque/s use ( su* outcomes4 7#b7 ,limitation ,if ! ,secret>y makes a det]m9ation "u p>agraph 7#a77;,a71 ! ,secret>y %all provide writt5 notice ( su* det]m9ation to ! sponsor1 includ+ a public heal? ju/ification = su* det]m9ation1 & su* notice %all be made "p ( ! adm9i/rative record4 ,su* det]m9ation %all n be delegat$ bel[ ! director ( ! ag5cy c5t] t is *>g$ ) ! prem>ket review ( ! eligible inve/igational drug4 7d7 ,report+ 7#a7 ,9 g5]al ,! manufactur] or sponsor ( an eligible inve/igational drug %all submit to ! ,secret>y an annual summ>y ( any use ( su* drug "u ?is section4 ,! summ>y %all include ! numb] ( doses suppli$1 ! numb] ( pati5ts treat$1 ! uses = :i* ! drug 0 made available1 & any kn[n s]i\s adv]se ev5ts4 ,! ,secret>y %all specify by regulation ! deadl9e ( submission ( su* annual summ>y & may am5d section #cab4cc ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations7 to require ! submission ( su* annual summ>y 9 conjunction ) ! annual report = an applicable inve/igational new drug application = su* drug4 7#b7 ,po/+ ( in=mation ,! ,secret>y %all po/ an annual summ>y report ( ! use ( ?is section on ! int]net website ( ! ,food & ,drug ,adm9i/ration1 includ+ ! numb] ( drugs = :i* cl9ical outcomes associat$ ) ! use ( an eligible inve/igational drug pursuant to ?is section 0-- 7,a7 us$ 9 accordance ) subsection 7c77#a77;,a72 7,b7 us$ 9 accordance ) subsection 7c77#a77;,b72 & 7,c7 n us$ 9 ! review ( an application "u section #eje ( ?is ,act or section #cea ( ! ,public ,heal? ,s]vice ,act4 4 7b7 ,no ,liability 7#a7 ,alleg$ acts or omissions ,) respect to any alleg$ act or omission ) respect to an eligible inve/igational drug provid$ to an eligible pati5t pursuant to section #efa;,b ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act & 9 compliance ) su* section1 no liability 9 a cause ( action %all lie aga9/-- 7,a7 a sponsor or manufactur]2 or 7,b7 a prescrib]1 disp5s]1 or o!r individual entity 7o!r ?an a sponsor or manufactur]71 unless ! relevant conduct con/itutes reckless or willful misconduct1 gross neglig5ce1 or an int5tional tort "u any applicable ,/ate law4 7#b7 ,det]m9ation n to provide drug ,no liability %all lie aga9/ a sponsor manufactur]1 prescrib]1 disp5s] or o!r individual entity = its det]m9ation n to provide access to an eligible inve/igational drug "u section #efa;,b ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act4 7#c7 ,limitation ,except z set =? 9 p>agraphs 7#a7 & 7#b71 no?+ 9 ?is section %all be con/ru$ to modify or o!rwise affect ! "r ( any p]son to br+ a private action "u any ,/ate or ,f$]al product liability1 tort1 consum] protection1 or w>ranty law4 #c4 ,s5se ( ! ,s5ate ,x is ! s5se ( ! ,s5ate t section #efa;,b ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1 z add$ by section #b-- 7#a7 does n e/abli% a new entitlem5t or modify an exi/+ entitlem5t1 or o!rwise e/abli% a positive "r to any p>ty or individual2 7#b7 does n e/abli% any new m&ates1 directives1 or additional regulations2 7#c7 only exp&s ! scope ( individual lib]ty & ag5cy among pati5ts1 9 limit$ circum/ances2 7#d7 is consi/5t )1 & w act z an alt]native pa?way alongside1 exi/+ exp&$ access policies ( ! ,food & ,drug ,adm9i/ration2 7#e7 w n1 & _c1 create a cure or effective !rapy :]e none exi/s2 7#f7 recognizes t ! eligible t]m9ally ill pati5t population (t5 consi/s ( ^? pati5ts ) ! highe/ risk ( mortality1 & use ( exp]im5tal treatm5ts "u ! crit]ia & proc$ure describ$ 9 su* section #efa;,a involves an in=m$ assumption ( risk2 & 7#g7 e/abli%es national /&>ds & rules by :i* inve/igational drugs may be provid$ to t]m9ally ill pati5ts4 ,pass$ ! ,s5ate ,augu/ #c1 #bjag4,secret>y